We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GKOS market cap is 5.27B. The company's latest EPS is USD -2.7221 and P/E is -39.12.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 71.27M | 71.23M | 73.9M | 80.4M | 78.05M |
Operating Income | -21.61M | -34.63M | -32.99M | -29.08M | -28.01M |
Net Income | -27.58M | -32.36M | -34.63M | -32.81M | -30.44M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 236.98M | 224.96M | 294.01M | 282.86M | 314.71M |
Operating Income | -50.29M | -123.55M | -62.87M | -113.21M | -128.7M |
Net Income | 15.42M | -120.35M | -49.59M | -100.1M | -134.66M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.01B | 1B | 972.59M | 956.74M | 948.63M |
Total Liabilities | 459.91M | 472.38M | 464.08M | 467.93M | 470.98M |
Total Equity | 548.55M | 530.01M | 508.51M | 488.81M | 477.66M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 818.4M | 1.01B | 1.05B | 1B | 940.41M |
Total Liabilities | 145.13M | 338.05M | 462.55M | 472.38M | 478.65M |
Total Equity | 673.27M | 667.45M | 587.15M | 530.01M | 461.77M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -28.95M | -33.08M | -30.76M | -38.93M | -47.09M |
Investing | 28.12M | 44.78M | -13.83M | 12.12M | 27.02M |
Financing | 5.72M | 6.25M | 1.15M | 272k | 7.74M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -369k | -22.99M | 24.71M | -33.08M | -57.76M |
Investing | 43.43M | -205.06M | -58.23M | 44.78M | 14.1M |
Financing | -9.65M | 262.54M | 39.26M | 6.25M | 15.04M |
Market Cap | 5.27B |
Price to Earnings Ratio | -39.12 |
Price to Sales Ratio | 16.74 |
Price to Cash Ratio | 56.36 |
Price to Book Ratio | 11.41 |
Dividend Yield | - |
Shares Outstanding | 49.47M |
Average Volume (1 week) | 577.91k |
Average Volume (1 Month) | 497.02k |
52 Week Change | 133.11% |
52 Week High | 108.22 |
52 Week Low | 45.47 |
Spread (Intraday) | 12.84 (11.67%) |
Company Name | Glaukos Corporation |
Address |
1201 north market st fl wilmington, delaware 19801 |
Website | https://www.glaukos.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions